During the past decade, Kindai University Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 19 clinical trials were completed, i.e. on average, 40.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 10 clinical trials were completed. i.e. 43.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kindai University Hospital" #1 sponsor was "Hoffmann-La Roche" with 25 trials, followed by "Pfizer" with 8 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Daiichi Sankyo Co., Ltd." with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kindai University Hospital" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Human Genome Center, Institute of Medical Science, University of Tokyo" with 2 trials as a collaborator and "Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Kindai University Hospital" are "Carcinoma, Renal Cell" (5 trials), "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Hepatocellular" (3 trials), "Hepatocellular Carcinoma" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Kindai University Hospital" in a lesser frequency.

Most popular intervention types in "Kindai University Hospital" are "Drug" (63 trials), "Biological" (5 trials), "Procedure" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (13 trials), "Placebo" (10 trials), "Cisplatin" (6 trials), "Carboplatin" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Kindai University Hospital" are 72 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kindai University Hospital". undefined are not yet recruiting, 13 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Kindai University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kindai University Hospital, 9 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".